LRRC1 and leukemia: While PSMA3, LRRC1, HNRNPD, and FAM98A demonstrated strong binding to HHT in vitro using purified proteins, their weaker engagement in leukemia cellular models highlights fundamental differences between simplified biochemical systems and complex physiological environments.